Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02226432 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Combined Antagonistic Muscle Magnetic Stimulation and Selective Periferal Neurotomy to Improve Results on Spasticity

Study acronym: Andreani2
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Aug 2025 to Nov 2026
    • Start date: May 2024 to Mar 2025
    • Study completion date: Mar 2026 to Mar 2027
    v20
  2. Primary completion date: Aug 2023 to Aug 2025
    • Start date: Apr 2023 to May 2024
    • Study completion date: Mar 2024 to Mar 2026
    v19
  3. Start date: Dec 2021 to Apr 2023v18
  4. Primary completion date: Aug 2021 to Aug 2023
    • Start date: Dec 2020 to Dec 2021
    • Study completion date: Mar 2023 to Mar 2024
    v17
  5. Primary completion date: Aug 2020 to Aug 2021
    • Start date: Dec 2019 to Dec 2020
    • Study completion date: Mar 2022 to Mar 2023
    v16
Show 14 earlier versionsHide 14 earlier versions
  1. Start date: Mar 2019 to Dec 2019
    • Primary completion date: Mar 2020 to Aug 2020
    • Study completion date: Dec 2021 to Mar 2022
    v15
  2. Start date: Dec 2018 to Mar 2019
    • Primary completion date: Aug 2020 to Mar 2020
    v14
  3. Lead sponsor: Juan Carlos M. Andreani to Juan Carlos M. Andreani MDv13
  4. Primary completion date: Aug 2018 to Aug 2020
    • Start date: Dec 2017 to Dec 2018
    • Study completion date: Dec 2019 to Dec 2021
    v12
  5. Interventions: - Postoperative Antagonistic Peripheral Magnetic Stimulation (Procedure), Kinesics (Other), Selected Peripheral Magnetic Stimulation… to - Postoperative Antagonistic Peripheral Magnetic Stimulation (Procedure), Kinesics (Other), Selective Peripheral Magnetic Stimulation…v11
  6. Start date: May 2017 to Dec 2017v10
  7. Start date: Mar 2017 to May 2017
    • Trial status: Enrolling by Invitation to Not Yet Recruiting
    • Primary completion date: Jun 2018 to Aug 2018
    v9
  8. Start date: Oct 2016 to Mar 2017
    • Primary completion date: Apr 2018 to Jun 2018
    v8
  9. Re-verified, no change to tracked fieldsv7
  10. Primary completion date: Oct 2017 to Apr 2018
    • Study completion date: Dec 2018 to Dec 2019
    • Secondary endpoints expanded, about 6 words
    v6
  11. Start date: Apr 2016 to Oct 2016
    • Primary completion date: Apr 2017 to Oct 2017
    • Study completion date: Dec 2017 to Dec 2018
    v5
  12. Primary completion date: Aug 2016 to Apr 2017
    • Start date: Aug 2015 to Apr 2016
    • Study completion date: Apr 2017 to Dec 2017
    v4
  13. Primary completion date: Aug 2015 to Aug 2016v3 Show 5 more changesShow less
    • Start date: Aug 2014 to Aug 2015
    • Study completion date: Aug 2015 to Apr 2017
    • Interventions: - Postoperative Peripheral Magnetic Stimulation (Procedure), Magnetic Stimulation with 1.5 tesla intensity (Device) to - Postoperative Antagonistic Peripheral Magnetic Stimulation (Procedure), Kinesics (Other), Selected Peripheral Magnetic Stimulation…
    • Study title shortened, about 6 words
    • Study arms: 1 to 3
  14. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of the present trial is to demonstrate Magnetic stimulation as an useful complementary treatment in order to improve patients' evolution without the need of extensive surgical lesion.
Trial Details
NCT Number NCT02226432
Lead Sponsor Juan Carlos M. Andreani MD
Conditions
(from sponsor)		 STROKE
Related terms Muscle Spasticity, Stroke
Enrollment 15 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov